The data from Wree et al. further indicated that reduced adiponectin levels may establish a proinflammatory milieu, thus increasing vulnerability to lipotoxicity, exacerbating hepatocytes injury, which promotes progression from simple steatosis to NASH and even advanced hepatic fibrosis [53]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.